Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pLenti_dCas9-2xAM Citations (2)

Originally described in: enChIP systems using different CRISPR orthologues and epitope tags.
Fujita T, Yuno M, Fujii H BMC Res Notes. 2018 Feb 27;11(1):154. doi: 10.1186/s13104-018-3262-4. PubMed Journal

Articles Citing pLenti_dCas9-2xAM

Articles
Guidelines for optimized gene knockout using CRISPR/Cas9. Campenhout CV, Cabochette P, Veillard AC, Laczik M, Zelisko-Schmidt A, Sabatel C, Dhainaut M, Vanhollebeke B, Gueydan C, Kruys V. Biotechniques. 2019 Jun;66(6):295-302. doi: 10.2144/btn-2018-0187. Epub 2019 May 1. PubMed
Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer. Akincilar SC, Chua JYH, Ng QF, Chan CHT, Eslami-S Z, Chen K, Low JL, Arumugam S, Aswad L, Chua C, Tan IB, DasGupta R, Fullwood MJ, Tergaonkar V. Nucleic Acids Res. 2022 Jun 14. pii: 6605892. doi: 10.1093/nar/gkac479. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.